Published in NPJ Schizophr on May 06, 2015
SCAN. Schedules for Clinical Assessment in Neuropsychiatry. Arch Gen Psychiatry (1990) 8.52
Characteristics of a soluble nuclear antigen precipitating with sera of patients with systemic lupus erythematosus. J Immunol (1966) 7.40
A serum factor in lupus erythematosus with affinity for tissue nuclei. Br Med J (1957) 4.85
The Comprehensive Assessment of Symptoms and History (CASH). An instrument for assessing diagnosis and psychopathology. Arch Gen Psychiatry (1992) 4.54
International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies. Ann Rheum Dis (2013) 3.99
A DNA-reacting factor in serum of a patient with lupus erythematosus diffusus. Proc Soc Exp Biol Med (1957) 3.59
Evidence-based guidelines for the use of immunologic tests: antinuclear antibody testing. Arthritis Rheum (2002) 2.99
The clinical utility of a positive antinuclear antibody test result. Am J Med (2013) 2.23
Prevalence and sociodemographic correlates of antinuclear antibodies in the United States. Arthritis Rheum (2012) 2.09
Immunologic and coagulation disorders in chlorpromazine-treated patients. Ann Intern Med (1979) 1.35
Genetic Risk and Outcome of Psychosis (GROUP), a multi-site longitudinal cohort study focused on gene-environment interaction: objectives, sample characteristics, recruitment and assessment methods. Int J Methods Psychiatr Res (2012) 1.21
Chlorpromazine-induced lupus anticoagulant and associated immunologic abnormalities. Am J Hematol (1982) 1.16
The epidemiologic evidence linking autoimmune diseases and psychosis. Biol Psychiatry (2013) 1.01
Clinical significance of autoantibodies in autoimmune hepatitis. J Autoimmun (2013) 0.93
A systematic, quantitative review of blood autoantibodies in schizophrenia. Schizophr Res (2013) 0.91
Spectrum of autoantibodies in Tunisian psychiatric inpatients. Immunol Invest (2012) 0.91
Chlorpromazine-induced antinuclear factors. Acta Med Scand (1970) 0.91
Neuroleptic-associated autoantibodies. A prevalence study. Biol Psychiatry (1990) 0.87
Autoantibody reactivity in serum of patients with major depression, schizophrenia and healthy controls. Psychiatry Res (2007) 0.85
Aberrant T cell-mediated immunity in untreated schizophrenic patients: deficient interleukin-2 production. Am J Psychiatry (1989) 0.85
Leukocytes and organ-nonspecific autoantibodies in schizophrenics and their siblings: markers of vulnerability or disease? Biol Psychiatry (1996) 0.83
Characterization and antigenic specificity of chlorpromazine-induced antinuclear antibodies. J Lab Clin Med (1986) 0.80
Autoantibodies to DNA in multicase families with schizophrenia. Biol Psychiatry (1993) 0.78
Antinuclear factors in relation to age, sex, mental disease and treatment with phenothiazines. Acta Psychiatr Scand Suppl (1974) 0.78
Factors related to the presence of autoantibodies in patients with chronic mental disorders. Biol Psychiatry (1990) 0.78
Antinuclear and gastric parietal cell autoantibodies in schizophrenic patients. Biol Psychiatry (1992) 0.77
Antinuclear antibodies in chronic psychotic patients treated with chlorpromazine. Am J Psychiatry (1975) 0.77
Antinuclear autoantibodies in chronic schizophrenia. Acta Psychiatr Scand (1995) 0.76
Genetic Risk and Outcome of Psychosis (GROUP), a multi-site longitudinal cohort study focused on gene-environment interaction: objectives, sample characteristics, recruitment and assessment methods. Int J Methods Psychiatr Res (2012) 1.21
GWA study data mining and independent replication identify cardiomyopathy-associated 5 (CMYA5) as a risk gene for schizophrenia. Mol Psychiatry (2010) 1.00
Clinical response to antipsychotic drug treatment: association study of polymorphisms in six candidate genes. Eur Neuropsychopharmacol (2012) 0.82
Is a schizo-obsessive subtype associated with cognitive impairment? Results from a large cross-sectional study in patients with psychosis and their unaffected relatives. J Nerv Ment Dis (2013) 0.77
No evidence for the presence of neuronal surface autoantibodies in plasma of patients with schizophrenia. Eur Neuropsychopharmacol (2015) 0.76
Psychometric properties of the self-report version of the Quick Inventory of Depressive Symptoms (QIDS-SR₁₆) questionnaire in patients with schizophrenia. BMC Psychiatry (2014) 0.76
The association between antibodies to neurotropic pathogens and schizophrenia: a case-control study. NPJ Schizophr (2015) 0.75
Obsessive-compulsive symptoms and overall psychopathology in psychotic disorders: longitudinal assessment of patients and siblings. Eur Arch Psychiatry Clin Neurosci (2016) 0.75
Cannabis and a lower BMI in psychosis: What is the role of AKT1? Schizophr Res (2016) 0.75
A state-independent network of depressive, negative and positive symptoms in male patients with schizophrenia spectrum disorders. Schizophr Res (2017) 0.75
A symptom network structure of the psychosis spectrum. Schizophr Res (2017) 0.75